Role of lymphadenectomy in management of adenocarcinoma of the endometrium

Purpose: To review the role of lymphadenectomy (LND) for patients with endometrial adenocarcinoma.

Methods: A review was undertaken of the English Language literature dealing with the role of LND for patients with endometrial adenocarcinoma (EC).

Results: The prognostic value of node status for EC patients has been recognized. LND performed by experienced surgeons has acceptable morbidity. Multiple series have suggested that significantly less external beam radiation is given to patients with known negative nodes. The decreased use of postop whole pelvic radiation has potential cost savings. However a survival advantage for LND has not yet been proven in a randomized clinical trials. United Kingdom investigators have begun a trial to determine if there is a demonstrable survival advantage for EC patients who undergo LND.

Conclusion: Although the morbidity, potential cost savings, and prognostic impact of node status are well accepted, it remains controversial as to whether LND provides a survival advantage. Trials are underway.

Surgical staging; Endometrial adenocarcinoma

[1] Announcements. F IGO Stages, 1988 Revision. Gynecol. Oneal., 1989, 35, 125.

[2] Creasman W.T., Morrow C.P., Bundy B.N. et al.: "Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study". Cancer, 1987, 60, 2035.

[3] Boronow R.C., Morrow C.P., Creasman W.T. et al.: "Surgical staging in endometrial cancer: clinical pathologic findings of aprospective study". Ob stet. Gynecol., 1984, 63, 825.

[4] Orr J.W. Jr., Holiman J.L.. Orr P.F: "Stage I corpus cancer: is teletherapy necessary?". Am. J. Obstet. Gynecol., 1997, 176, 777.

[5] Naumann R.W., Higgins R.V., Hall J.B.: "The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists". Gynecol. Oneal., 1999, 75, 4.

[6] Straughn J.M., Huh W.K., Kelley F.J. et al.: "Conservative management of stage I endometrial carcinoma after surgical staging" Gynecol. Oneal., 2002, 84, 194.

[7] Gretz H.F. 3'', Economos K., Husein A. et al.:'The practice of surgical staging and its impact on adjuvant recommendations in pateints with Stage I endometrial carcinoma". Gynecol. Oneal., 1996, 61, 409.

[8] Homesley H.D., Kadar N., Barret R.J. et al.: "Selective pelvic and para-aortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma". Am. J. Obstet. Gynecol., 1992, 167, 1225.

[9] Barnes M., Roland P.Y., Straughn J.M. et al.: "A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact". Gynecol. Oneal., 1999, 74, 443.

[10] Kilgore L.C., Partridge E.E., Alvarez R.D. et al.: "Adenocarcinoma of the endometrium: survival comparisons of patients withand without pelvic node sampling". Gynecol. Oneal., 1995, 56, 29.

[11] DiSaia P.J., Creasman W.T., Boronow R.C. et al.: "Risk factors and recurrent patterns in Stage I endometrial cancer". Am. J. Obstet. Gynecol., 1985, 151, 1009.

[12] Horowitz N.S., Powell M.A., Smith J.H. et al.: "Staging grade I endometrial cancers: saving dollars and saving lives" (abstract) PROC. ASCO, 2003, 22, 457, 1835.

[131 Fanning J.: "Long-term survival of intermediate risk endometrial cancer (Stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy w/o teletherapy". Gynecol. Oneal., 2001, 82, 371.

[14] Mohan D.S., Samuels M.A., Selim M.A. et al.: "Long-term outcomes of therapuetic pelvic lymphadenectomy for Stage I endometrial adenocarcinoma". Gynecol. Oneal., 70, 165.

[15] Seago D.P., Raman A., Lele S.: "Potential benefit of lymphadenectomy for the treatment of node negative locally advanced utenne cancer". Gynecol. Oneal., 2001, 83, 282.

[16] Ball H. [personal communication July 2003].

[17] Creasman W.T., Odicino F., Maisonnueve P. et al.: "Carcinoma of the corpus uteri". J. Epidemiol. Biostat., 2001, 6, 47.

[18] Keys H.M., Roberts J.A., Brunetto V.L. et al.: "A phase III trial of surgery with or without adjunctive external pelvic radiation in intermediate risk endometrial adenocarcinoma. A Gynecologic Oncology Group Study". Gynecol. Oneal., 2004, 92, 744.

[19] Hicks M.L., Fiver M.S., Puretz J.L. et al.: "Survival in patients with paraortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus". Int. J. Radiat. Oneal. Biol. Phys., 1993, 26, 607.

[20] Onda T., Yoshikawa H., Mizutani K. et al.: "Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy". Br. J. Cancer, 1997, 75, 1836.

[21] Bristow R.E., Zahurak M.L., Alexander CJ. et al.: "F IGO Stage IIIC endometrial cancer: resection of macroscopic nodal disease and other determinants of survial". Int. J. Gyn. Cancer, 2003, 13, 664.

[22] Larson D.M., Broste S.K., Krawisz B.R.: "Surgery without radiotherapy for primary treatment of endometrial cancer". Obstet. Gynecol., 1998, 91, 355.

[23] Morrow C.P., Bundy B.N., Kurman R.J. et al.: "Relationship between surgical pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group Study". Gynecol. Oneal., 1991, 40, 55.

[24] Larson D.M., Johnson K., Olson K.A.: "Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbibity and mortality". Obstet. Gynecol., 1992, 79, 998.

[25] Cliby W.A., Clarke-Pearson D.L., Dodge R. et al.: "Acute morbibity and mortality associated with selective pelvic and para-aortic lymphadenectomy in the surgical staging of endometrial adenocarcinoma". J. Gynecol. Tech., 1995, 1, 19.

[26] Franchi M., Ghezzi F., Riva C. et al.: "Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer". J. Surg. Oneal., 2001, 78, 232.

[27] Everett E., Tamimi H.,Greer B. et al.: "The effect of body mass index on clinical/pathologic features, surgical morb心ty and outcome in patients with endometrial cancer". Gynecol. Oneal., 2003, 90, 150.

[28] Girardi F, Petru E., Hedarfadai M. et al.: "Pelvic lymphadenectomy in the surgical treatment of endometrial cancer". Gynecol Oneal., 1993, 49, 177.

[29] Lewandowski G., Torrisi J., Potkul R.K. et al.: "Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: a comparison of complication rates". Gynecol. Oneal., 1990, 36, 401.

[30] Corn B.W., Lanciano R.M., Greven K.M. et al.: "Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis". J. Clin. Oneal., 1994, 12,510.

[31] Ashih H., Gustilo-Ashby T., Myers E.R. et al.: "Cost effectiveness of treatment of early stage endometrial cancer". Gynecol. Oneal., 1999, 74, 208.

[32] Chuang L., BurKe. T.W. Marino B.D. et al.: "Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal nodes". Gynecol. Oncol., 1995, 58, 189.

[33] Mariani A., Webb M.J., Galli L. et al.: "Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer". Gynecol. Oneal., 2000, 76, 348.

[34] Creutzberg C.L., van Putten W.L., Koper P.C.M. et al. for the PORTEC Study Group: "Surgery and postoperative radiotherapy verus surgery alone for patients with Stage I endometrial carcinoma: multicentre randomised trial". Lancet, 2000, 355, 1404.

[35] Randall M.R., Brunetto G., Muss H. et al.: "Whole abdominal radiotherapy versus combination chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group" (abstract). Proc. Am. Society Clin. Oncol., 2003, 22, 2.

[36] Phase III randomized study of lymphadenectomy and adjuvant external beam radiotherapy in patients with endometrial cancer. MRC-ASTEC EU-98062 [www.nci.nih.gov/clinicaltrials viewed 12/5/03] role of lymphadenectomy.doc.